Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition Michelle Willihnganz All Chapters (1-48) |A+ ULTIMATE GUIDE 2023

Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition
N N N N N N N N N 1




COMPELETE TESTBANK N




TESTBANK FOR CLAYON’S BASIC PHARMACOLOGY
N N N N




FOR NURSES 19TH EDITION/ WILLIHNGANZ VERIFIED
N N N N N N




QUESTIONS AND ANSWERS WITH 2024 UPDATES (ALL
N N N N N N N




CHAPTERS INLUDED 1-48)
N N N

,Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition
N N N N N N N N N 2




Chapter 01: Drug Definitions, Standards, and Information Sources Willihnganz:
N N N N N N N N




Clayton’s Basic Pharmacology for Nurses, 19th Edition
N N N N N N N




1. Which name identifies a drug listed bythe US Food Drug
N N N N N N N N N N




Administration (FDA)?
N N




a. Bran
b. Nonproprietar
c. Official
d. Trademark
ANS:
The official name is the name under which a drug is listed by the
N N N N N N N N N N N N N




FDA. The brand name, or trademark, is the name given to a drug
N N N N N N N N N N N N N




by its manufacturer. The nonproprietary, or generic, name is
N N N N N N N N N




provided by the United States Adopted Names Council.
N N N N N N N N




Cognitive Level: Knowledge REF: p. 9 N N N N




OBJ: 1NAT: NCLEX Client Needs Category: Safe, Effective Care N N N N N N N N




Environment TOP: Nursing Process Step: Assessment
N CON: N N N N N




Patient Education
N N




2. Which source contains information specific to nutritional supplements?
N N N N N N N




a. USP Dictionary of USAN &International Drug Names
N N N N N N N




b. Natural Medicines Comprehensive Database N N N




c. United States Pharmacopoeia/National Formulary (USP NF) N N N N N




d. Drug Interaction Facts N N




ANS: C N




United States Pharmacopoeia/National Formulary contains information specific to nutritional
N N N N N N N N




supplements. USP Dictionary of USAN & International Drug Names is a compilation of drug names,
N N N N N N N N N N N N N N N




pronunciation guide, and possible future FDA approved drugs; it does not include nutritional
N N N N N N N N N N N N N




supplements. Natural Medicines Comprehensive Database contains
N N N N N N




evidence-based information on herbal medicines and herbal combination products; it does not N N N N N N N N N N N




include information specific to nutritional supplements. Drug Interaction Facts contains
N N N N N N N N N N




comprehensive information on drug interaction facts; it does not include nutritional
N N N N N N N N N N N




supplements.
N




DIF: Cognitive Level: Knowledge REF: p. 4 OBJ: 3 N N N N N




NAT: NCLEX Client Needs Category: Physiological Integrity
N N N N N N N




TOP: Nursing Process Step: Assessment
N CON: Nutrition |Patient Education N N N N N N N




3. Which drug reference contains drug monographs that describe all drugs in a therapeutic class?
N N N N N N N N N N N N N




a. Drug Facts and Comparisons N N N

,Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition
N N N N N N N N N 3

b. Drug Interaction Facts N N




c. Handbook on Injectable Drugs N N N




d. Martindale—The Complete Drug Reference N N N




ANS: A N




Drug Facts and Comparisons contains drug monographs that describe all drugs in a
N N N N N N N N N N N N




therapeutic class. Monographs are formatted as tables to allow comparison of similar
N N N N N N N N N N N N




products, brand names, manufacturers, cost indices, and available dosage forms Online
N N N N N N N N N N N




version is available.
N N N




DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 N N N N N N




OBJ: 3 N NAT: NCLEX Client Needs Category: Physiological Integrity
N N N N N N N




TOP: Nursing Process Step: Assessment
N CON: Safety | Patient Education | Clinical Judgment
N N N N N N N N N N




4. Which drug reference contains monographs about virtuallyeverysingle-entitydrug available in
N N N N N N N N N N N




the United States and describes therapeutic uses of drugs, including approved and unapproved
N N N N N N N N N N N N N




uses?
N




a. Martindale: The Complete Drug Reference N N N N




b. AHFS Drug Information N N




c. Drug Reference N




d. Drug Facts and Comparisons N N N




ANS: B N




AHFS Drug Information contains monographs about virtually every single-entity drug
N N N N N N N N N




available in the United States and describes therapeutic uses of drugs, including approved and
N N N N N N N N N N N N N N




unapproved uses.
N N




DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 N N N N N N




OBJ: 3 N NAT: NCLEX Client Needs Category: Physiological Integrity
N N N N N N N




TOP: Nursing Process Step: Planning
N CON: Safety | Patient Education | Clinical Judgment
N N N N N N N N N N




5. Which online drug reference makes available to healthcare providers and the public a
N N N N N N N N N N N N




standard, comprehensive, up-to-date look up and downloadable resource about medicines?
N N N N N N N N N N




a. American Drug Index N N




b. American Hospital Formulary N N




c. DailyMed
d. Drug Reference N




ANS: C N




DailyMed makes available to healthcare providers and the public a standard, comprehensive,
N N N N N N N N N N N




up-to-date look up and downloadable resource about medicines. The American Drug Index is not
N N N N N N N N N N N N N N




appropriate for patient use. The American Hospital Formulary is not appropriate for patient
N N N N N N N N N N N N N




use. The drug reference is not appropriate for patient use.
N N N N N N N N N N




DIF: Cognitive Level: Knowledge REF: p. 3 | p. 4 N N N N N N N OBJ: 3 N




NAT: NCLEX Client Needs Category: Physiological Integrity
N N N N N N N




TOP: Nursing Process Step: Implementation
N N N N




CON: Safety |Patient Education | Clinical Judgment
N N N N N N N




6. Which legislation authorizes the FDA to determine the safetyof a drug before its marketing?
N N N N N N N N N N N N N N




a. Federal Food, Drug, and Cosmetic Act (1938) N N N N N N




b. Durham Humphrey Amendment (1952) N N N

, Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition
N N N N N N N N N 4

c. Controlled Substances Act (1970) N N N




d. Kefauver Harris Drug Amendment (1962) N N N N




ANS: A N




The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the safety
N N N N N N N N N N N N N N N




of all drugs before marketing. Later amendments and acts helped tighten FDA control and
N N N N N N N N N N N N N N




ensure drug safety. The Durham Humphrey Amendment defines the kinds of drugs that cannot
N N N N N N N N N N N N N N




be used safely without medical supervision and restricts their sale to prescription by a licensed
N N N N N N N N N N N N N N N




practitioner. The Controlled Substances Act addresses onlycontrolled substances and their
N N N N N N N N N N N




categorization. The Kefauver Harris Drug Amendment ensures drug efficacy and greater drug
N N N N N N N N N N N N




safety. Drug manufacturers are required to prove to the FDA the effectiveness of their products
N N N N N N N N N N N N N N N




before marketing them.
N N N




DIF: Cognitive Level: Knowledge REF: p. 5 Table l.3 N N N N N N




OBJ: 5 NAT: NCLEX Client Needs Category: Physiological Integrity
N N N N N N N




TOP: Nursing Process Step: Assessment
N N N N N




CON: Safety | Patient Education | Evidence | Health Care Law
N N N N N N N N N N




7. Which classification does meperidine (Demerol) fall under?
N N N N N N




a. I
b. II
c. III
d. IV
ANS: B N




Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may lead to
N N N N N N N N N N N N N N N N N




severe psychological and physical dependence. Schedule I drugs have high potential for abuse and
N N N N N N N N N N N N N N




no recognized medical use. Schedule III drugs have some potential for abuse. Use may lead to
N N N N N N N N N N N N N N N N




low to moderate physical dependence or high psychological dependence. Schedule IV drugs
N N N N N N N N N N N N




have low potential for abuse. Use may lead to limited physical or psychological dependence.
N N N N N N N N N N N N N N




DIF: Cognitive Level: Knowledge REF: p. 10 OBJ: 2 N N N N N




NAT: NCLEX Client Needs Category: Safe, Effective Care Environment
N N N N N N N N N




TOP: Nursing Process Step: Assessment
N CON: Patient Education | Addiction |Pain
N N N N N N N N N




8. Which action would the FDA take to expedite drug development and approval for an outbreak of
N N N N N N N N N N N N N N N




smallpox?
N




a.List smallpox as a health orphan disease.
N N N N N N




b.Omit the preclinical research phase. N N N N




c.Extend the clinical research phase. N N N N




d.Fast track the investigational drug. N N N N




ANS: D N




Once the Investigational New Drug Application has been approved, the drug can receive highest
N N N N N N N N N N N N N




priority within the agency, which is called fast tracking. A smallpox outbreak would become a
N N N N N N N N N N N N N N N




priority concern in the world. Orphan diseases are not researched in a priority manner.
N N N N N N N N N N N N N N




Preclinical research is not omitted. Extending any phase of the research would mean a longer
N N N N N N N N N N N N N N N




time to develop a vaccine. The FDA must ensure that all phases of the preclinical and clinical
N N N N N N N N N N N N N N N N N




research phase have been completed in a safe manner.
N N N N N N N N N




DIF: Cognitive Level: Knowledge N N REF: p. 7 N N OBJ: 5 N